Literature DB >> 32486341

Lipid Metabolism in Development and Progression of Hepatocellular Carcinoma.

Moris Sangineto1, Rosanna Villani1, Francesco Cavallone1, Antonino Romano2, Domenico Loizzi3, Gaetano Serviddio1.   

Abstract

: Metabolic reprogramming is critically involved in the development and progression of cancer. In particular, lipid metabolism has been investigated as a source of energy, micro-environmental adaptation, and cell signalling in neoplastic cells. However, the specific role of lipid metabolism dysregulation in hepatocellular carcinoma (HCC) has not been widely described yet. Alterations in fatty acid synthesis, β-oxidation, and cellular lipidic composition contribute to initiation and progression of HCC. The aim of this review is to elucidate the mechanisms by which lipid metabolism is involved in hepatocarcinogenesis and tumour adaptation to different conditions, focusing on the transcriptional aberrations with new insights in lipidomics and lipid zonation. This will help detect new putative therapeutic approaches in the second most frequent cause of cancer-related death.

Entities:  

Keywords:  fatty acid β-oxidation; hepatocellular carcinoma; lipid metabolism; lipidomics; non-alcoholic fatty liver disease; tumour progression

Year:  2020        PMID: 32486341     DOI: 10.3390/cancers12061419

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  25 in total

1.  Orlistat Resensitizes Sorafenib-Resistance in Hepatocellular Carcinoma Cells through Modulating Metabolism.

Authors:  Pei-Wei Shueng; Hui-Wen Chan; Wei-Chan Lin; Deng-Yu Kuo; Hui-Yen Chuang
Journal:  Int J Mol Sci       Date:  2022-06-10       Impact factor: 6.208

2.  Integrated Lipidomics and Metabolomics Study of Four Chemically Induced Mouse Models of Acute Intrahepatic Cholestasis.

Authors:  Weiwei Li; Hui Chen; Yihan Qian; Shouchuan Wang; Zichen Luo; Jinjun Shan; Xiaoni Kong; Yueqiu Gao
Journal:  Front Pharmacol       Date:  2022-06-08       Impact factor: 5.988

3.  Enrichment of progenitor cells by 2-acetylaminofluorene accelerates liver carcinogenesis induced by diethylnitrosamine in vivo.

Authors:  María Paulette Castro-Gil; Ricardo Sánchez-Rodríguez; Julia Esperanza Torres-Mena; Carlos David López-Torres; Valeria Quintanar-Jurado; Nayeli Belem Gabiño-López; Saúl Villa-Treviño; Luis Del-Pozo-Jauner; Jaime Arellanes-Robledo; Julio Isael Pérez-Carreón
Journal:  Mol Carcinog       Date:  2021-03-25       Impact factor: 4.784

4.  Oral Cyanobacteria and Hepatocellular Carcinoma.

Authors:  Brenda Y Hernandez; Xuemei Zhu; Harvey A Risch; Lingeng Lu; Xiaomei Ma; Melinda L Irwin; Joseph K Lim; Tamar H Taddei; Karen S Pawlish; Antoinette M Stroup; Robert Brown; Zhanwei Wang; Linda L Wong; Herbert Yu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-10-25       Impact factor: 4.090

5.  Fidgetin as a potential prognostic biomarker for hepatocellular carcinoma.

Authors:  Bin Zhou; Jisheng Wang; Jing Gao; Junqing Xie; Yiming Chen
Journal:  Int J Med Sci       Date:  2020-10-16       Impact factor: 3.738

6.  Development of a novel lipid metabolism-based risk score model in hepatocellular carcinoma patients.

Authors:  Wenjie Wang; Chen Zhang; Qihong Yu; Xichuan Zheng; Chuanzheng Yin; Xueke Yan; Gang Liu; Zifang Song
Journal:  BMC Gastroenterol       Date:  2021-02-12       Impact factor: 3.067

7.  A Novel Nutraceuticals Mixture Improves Liver Steatosis by Preventing Oxidative Stress and Mitochondrial Dysfunction in a NAFLD Model.

Authors:  Moris Sangineto; Vidyasagar Naik Bukke; Francesco Bellanti; Rosanna Tamborra; Archana Moola; Loren Duda; Rosanna Villani; Antonino Davide Romano; Gaetano Serviddio
Journal:  Nutrients       Date:  2021-02-17       Impact factor: 5.717

Review 8.  Etiology of Hepatocellular Carcinoma: Special Focus on Fatty Liver Disease.

Authors:  Diwakar Suresh; Akshatha N Srinivas; Divya P Kumar
Journal:  Front Oncol       Date:  2020-11-30       Impact factor: 6.244

9.  Anthracyclins Increase PUFAs: Potential Implications in ER Stress and Cell Death.

Authors:  David Balgoma; Fredrik Kullenberg; Carlemi Calitz; Maria Kopsida; Femke Heindryckx; Hans Lennernäs; Mikael Hedeland
Journal:  Cells       Date:  2021-05-11       Impact factor: 6.600

10.  High expression of PARD3 predicts poor prognosis in hepatocellular carcinoma.

Authors:  Songwei Li; Jian Huang; Fan Yang; Haiping Zeng; Yuyun Tong; Kejia Li
Journal:  Sci Rep       Date:  2021-05-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.